Clover Health Investments, Corp. (FRA:7QD)
Germany · Delayed Price · Currency is EUR 2.238
+0.035 (1.59%)
At close: Jan 23, 2026
Clover Health Investments Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Premiums & Annuity Revenue | 1,737 | 1,345 | 1,243 | 1,178 | 688.79 | 682.83 |
Gain (Loss) on Sale of Investments | 0.93 | 0.01 | -4.71 | 8.95 | -0.05 | 1.11 |
Non-Insurance Activities Revenue | - | - | - | - | 667.64 | - |
Other Revenue | 36.09 | 25.77 | 24.75 | 11.95 | 5 | 6.08 |
| 1,774 | 1,371 | 1,263 | 1,199 | 1,361 | 690.02 | |
Revenue Growth (YoY) | 32.15% | 8.52% | 5.32% | -11.91% | 97.30% | 51.74% |
Policy Benefits | 1,398 | 1,006 | 1,005 | 993.07 | 1,551 | 590.08 |
Depreciation & Amortization | 1.61 | 1.33 | 2.51 | 1.19 | 1.25 | 0.56 |
Selling, General & Administrative | 308.78 | 290.81 | 324.02 | 367.98 | 349.01 | 127.91 |
Other Operating Expenses | - | - | - | 0.07 | 0.19 | - |
Total Operating Expenses | 1,831 | 1,417 | 1,447 | 1,477 | 1,998 | 782.72 |
Operating Income | -57.66 | -45.93 | -184.29 | -277.45 | -636.99 | -92.71 |
Interest Expense | - | - | -0.01 | -1.36 | -16.91 | -57.11 |
Other Non Operating Income (Expenses) | -0.05 | -0.05 | -0.09 | 0.9 | 66.15 | 13.42 |
EBT Excluding Unusual Items | -57.71 | -45.98 | -184.38 | -277.91 | -587.76 | -136.39 |
Merger & Restructuring Charges | - | -0.29 | -9.82 | - | - | - |
Impairment of Goodwill | - | - | -11.7 | - | - | - |
Asset Writedown | - | - | -4.25 | - | - | - |
Other Unusual Items | - | - | - | 23.33 | - | - |
Pretax Income | -57.71 | -46.27 | -210.15 | -254.58 | -587.76 | -136.39 |
Earnings From Continuing Ops. | -57.71 | -46.27 | -210.15 | -254.58 | -587.76 | -136.39 |
Earnings From Discontinued Ops. | -0.61 | 3.26 | -3.21 | -84.98 | - | - |
Net Income | -58.32 | -43.01 | -213.36 | -339.57 | -587.76 | -136.39 |
Net Income to Common | -58.32 | -43.01 | -213.36 | -339.57 | -587.76 | -136.39 |
Shares Outstanding (Basic) | 506 | 490 | 482 | 476 | 413 | 89 |
Shares Outstanding (Diluted) | 506 | 490 | 482 | 476 | 413 | 89 |
Shares Change (YoY) | 3.78% | 1.63% | 1.25% | 15.33% | 365.57% | 0.98% |
EPS (Basic) | -0.12 | -0.09 | -0.44 | -0.71 | -1.42 | -1.54 |
EPS (Diluted) | -0.12 | -0.09 | -0.44 | -0.71 | -1.42 | -1.54 |
Free Cash Flow | -86.38 | 33.29 | -145.25 | -208.39 | -283.05 | -119.19 |
Free Cash Flow Per Share | -0.17 | 0.07 | -0.30 | -0.44 | -0.69 | -1.34 |
Operating Margin | -3.25% | -3.35% | -14.59% | -23.13% | -46.79% | -13.44% |
Profit Margin | -3.29% | -3.14% | -16.89% | -28.31% | -43.17% | -19.77% |
Free Cash Flow Margin | -4.87% | 2.43% | -11.50% | -17.38% | -20.79% | -17.27% |
EBITDA | -56.05 | -44.6 | -181.78 | -276.26 | -635.75 | -92.15 |
EBITDA Margin | -3.16% | -3.25% | -14.39% | -23.04% | -46.70% | -13.36% |
D&A For EBITDA | 1.61 | 1.33 | 2.51 | 1.19 | 1.25 | 0.56 |
EBIT | -57.66 | -45.93 | -184.29 | -277.45 | -636.99 | -92.71 |
EBIT Margin | -3.25% | -3.35% | -14.59% | -23.13% | -46.79% | -13.44% |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.